Docetaxel - Carboplatin as Second Line Treatment in Patients With Small Cell Lung Cancer (DOCAR)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Jeroen Bosch Ziekenhuis.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Jeroen Bosch Ziekenhuis
Information provided by:
Jeroen Bosch Ziekenhuis
ClinicalTrials.gov Identifier:
NCT00686985
First received: May 27, 2008
Last updated: May 29, 2008
Last verified: May 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2010 |
| Estimated Primary Completion Date: | No date given |